What are Olema Pharmaceuticals, Inc.'s total assets?

Olema Pharmaceuticals, Inc. (OLMA) holds $530.6M in total assets, up 29.5% year over year.

How much debt does Olema Pharmaceuticals, Inc. have?

Olema Pharmaceuticals, Inc. carries $956.0K in total debt against $480.5M of shareholders' equity, a debt-to-equity ratio of 0.00.

How much cash does Olema Pharmaceuticals, Inc. have?

Olema Pharmaceuticals, Inc. holds $52.5M in cash and equivalents.

Can Olema Pharmaceuticals, Inc. cover its short-term obligations?

Its current ratio is 10.88 — current assets exceed current liabilities.

Where does Olema Pharmaceuticals, Inc.'s balance sheet data come from?

Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Olema Pharmaceuticals, Inc. OLMA Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$52.55M+8.8%	$48.3M+37.0%	$35.26M-32.8%	$52.47M+3.6%	$50.64M-63.7%
Short-term investments	$452.8M-0.9%	$457.14M+55.6%	$293.7M-5.1%	$309.44M-9.5%	$342.07M+16.1%
Prepaid expenses and other current assets	$29.08M+15.6%	$25.15M+28.8%	$19.52M+12.3%	$17.39M+18.6%	$14.66M+6.1%
Total current assets	$513.23M-0.4%	$515.45M+54.2%	$334.33M-9.1%	$367.73M-7.3%	$396.66M-9.5%
Operating lease right-of-use assets	$921K-19.6%	$1.15M-19.2%	$1.42M-15.8%	$1.69M+59.7%	$1.06M-19.7%
Total assets	$530.65M-0.5%	$533.43M+51.3%	$352.45M-7.7%	$382M-6.7%	$409.64M-9.2%
Accounts payable	$17.38M+25.8%	$13.81M+53.1%	$9.02M+9.6%	$8.23M-29.4%	$11.65M-39.2%
Accrued expenses	$42.49M+2.6%	$41.43M+11.9%	$37.01M+19.1%	$31.08M+24.9%	$24.89M-31.1%
Operating lease liabilities, current	$956K-14.9%	$1.12M-3.8%	$1.17M+1.3%	$1.15M+12.5%	$1.03M-12.5%
Total current liabilities	$47.17M-8.9%	$51.8M+24.4%	$41.66M+25.6%	$33.16M+27.2%	$26.06M-37.6%
Operating lease liabilities, non-current	$0-100%	$69K-77.7%	$310K-48.5%	$602K+389%	$123K-52.1%
Operating Lease Liabilities (Total)	$956K-19.9%	$1.19M-19.3%	$1.48M-15.8%	$1.76M+52.9%	$1.15M-19.7%
Total liabilities	$50.17M-8.6%	$54.87M+22.0%	$44.97M+22.3%	$36.77M+40.4%	$26.19M-37.7%
Common stock	$8K0.0%	$8K+14.3%	$7K0.0%	$7K0.0%	$7K0.0%
Additional paid-in capital	$1.13B+5.2%	$1.08B+25.3%	$858.45M+0.5%	$854.19M+0.7%	$848.52M+0.5%
Retained earnings	-$650.65M-8.9%	-$597.56M-8.4%	-$551.5M-8.3%	-$509.28M-9.4%	-$465.5M-7.0%
Accumulated other comprehensive income (loss)	-$460K-174%	$621K+18.1%	$526K+67.5%	$314K-25.2%	$420K+194%
Total stockholders' equity	$480.48M+0.4%	$478.56M+55.6%	$307.49M-10.9%	$345.24M-10.0%	$383.45M-6.2%
Total liabilities and stockholders' equity	$530.65M-0.5%	$533.43M+51.3%	$352.45M-7.7%	$382M-6.7%	$409.64M-9.2%
Short- term Investments	$452.8M-0.9%	$457.14M+55.6%	$293.7M-5.1%	$309.44M-9.5%	$342.07M+16.1%
Net Investment in Lease	$921K-19.6%	$1.15M-19.2%	$1.42M-15.8%	$1.69M+59.7%	$1.06M-19.7%
Operating lease right-of-use assets	$921K-19.6%	$1.15M-19.2%	$1.42M-15.8%	$1.69M+59.7%	$1.06M-19.7%
Other Assets And Long Term Deposits Non Current	$16.5M-2.0%	$16.83M+0.8%	$16.71M+32.7%	$12.59M+5.6%	$11.92M+6.5%
Operating Lease Right-of-Use Assets in Other Assets	$921K-19.6%	$1.15M-19.2%	$1.42M-15.8%	$1.69M+59.7%	$1.06M-19.7%
Other accrued liabilities	$42.49M+2.6%	$41.43M+11.9%	$37.01M+19.1%	$31.08M+24.9%	$24.89M-31.1%
Line of Credit Outstanding	$3M—	——	——	——	——
Total debt	$956K-19.9%	$1.19M-19.3%	$1.48M-15.8%	$1.76M+52.9%	$1.15M-19.7%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$8K0.0%	$8K+14.3%	$7K0.0%	$7K0.0%	$7K0.0%
Secured lines of credit	$3M—	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Olema Pharmaceuticals, Inc.'s total assets?: Olema Pharmaceuticals, Inc. (OLMA) holds $530.6M in total assets, up 29.5% year over year.
How much debt does Olema Pharmaceuticals, Inc. have?: Olema Pharmaceuticals, Inc. carries $956.0K in total debt against $480.5M of shareholders' equity, a debt-to-equity ratio of 0.00.
How much cash does Olema Pharmaceuticals, Inc. have?: Olema Pharmaceuticals, Inc. holds $52.5M in cash and equivalents.
Can Olema Pharmaceuticals, Inc. cover its short-term obligations?: Its current ratio is 10.88 — current assets exceed current liabilities.
Where does Olema Pharmaceuticals, Inc.'s balance sheet data come from?: Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.